Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Study Finds Certain Antibiotics Linked to Increased Mortality Rate and Organ Dysfunction Side effects of antibiotics like Zosyn were linked to more deaths among patients, leading researchers to question the use of antianaerobic antibiotics for sepsis. May 16, 2024 Grace Muller Add Your Comments The findings of a new study suggest that side effects of certain antibiotics used to treat sepsis may actually increase the risk of death and interfere with organ functions. Researchers from the University of Michigan warn that they found higher mortality rates among patients treated with vancomycin and piperacillin-tazobactam, compared to those treated with vancomycin and cefepime, in a report published this week in the medical journal JAMA Internal Medicine, concluding that the use of broad-spectrum antianaerobic antibiotics for sepsis treatment might cause unnecessary harm. Vancomycin and piperacillin-tazobactam are antibiotics used to treat bacterial infections. Vancomycin targets gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and is used for serious infections when other antibiotics fail. Piperacillin-tazobactam, sometimes sold under the brand name Zosyn, combines piperacillin, which disrupts bacterial cell walls, with tazobactam, which prevents bacterial resistance. Both antibiotics are commonly used in hospitals to treat severe infections like sepsis, which is a life-threatening condition that occurs when an individual’s immune system has a dangerous response to an infection and starts to damage the body’s tissues and organs. Symptoms of sepsis include decreased blood pressure, increased heart rate, fever, confusion, shortness of breath, weakness, and can result in organ failure or death. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In this latest study, researchers analyzed 7,569 sepsis patients during a 15-month piperacillin-tazobactam shortage. The study aimed to compare 90-day mortality rates in sepsis patients treated with either piperacillin-tazobactam or cefepime. The retrospective cohort study analyzed hospital admissions at the University of Michigan from July 1, 2014, to December 31, 2018, including the shortage period from June 12, 2015, to September 18, 2016. Researchers included data on adult patients suspected of having sepsis who were treated with vancomycin and either piperacillin-tazobactam or cefepime, where both treatments were deemed equally suitable. Researchers looked for data on 90-day mortality, with secondary outcomes measuring days free from organ failure, ventilator use, and vasopressor use. According to the findings, 4,523 received vancomycin and piperacillin-tazobactam, while 3,046 were treated with vancomycin and cefepime. A small number (3%) received piperacillin-tazobactam during the shortage. The analysis found that piperacillin-tazobactam was linked to a 5% increase in 90-day mortality and 2.1 fewer organ failure–free days, 1.1 fewer ventilator-free days and 1.5 fewer vasopressor-free days. “Among patients with suspected sepsis and no clear indication for antianaerobic coverage, administration of piperacillin-tazobactam was associated with higher mortality and increased duration of organ dysfunction compared with cefepime,” the researchers determined. “These findings suggest that the widespread use of empirical antianaerobic antibiotics in sepsis may be harmful.” Tags: Antibiotics, Infection, MRSA, Sepsis, Vancomycin, Zosyn More Lawsuit Stories Insulin Delivery Problems Lead to Tandem t:slim X2 Insulin Pump Recall: FDA August 13, 2025 Ford Rear Axle Recall Issued Due to Vehicle Rollaway Risks: NHTSA August 13, 2025 Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe August 12, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025) Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025) Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (Posted: 5 days ago) Lawsuits against Bard and AngioDynamics have been consolidated in separate MDLs, alleging that design defects in their implantable port catheter systems caused severe infections that were not properly disclosed. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)Cook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)
Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe (Posted: yesterday) A Cartiva implant lawsuit blames the manufacturer for failing to warn patients about high failure rates for years after it began receiving implant complication reports. MORE ABOUT: CARTIVA IMPLANT LAWSUITJudge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (07/28/2025)Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)
Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (Posted: 2 days ago) Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026. MORE ABOUT: BIOZORB LAWSUITFailed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)Lawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)
Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (Posted: 5 days ago) Lawsuits against Bard and AngioDynamics have been consolidated in separate MDLs, alleging that design defects in their implantable port catheter systems caused severe infections that were not properly disclosed. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)Cook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)